The cell surface glycoprotein CDCP1 in cancer—insights, opportunities, and challenges
A Wortmann, Y He, EI Deryugina, JP Quigley… - IUBMB …, 2009 - Wiley Online Library
In the last few years dysregulated expression of the cell surface glycoprotein CUB domain‐
containing protein 1 (CDCP1) has been associated with several cancers and this cell
surface molecule has been recognized both as a tumor marker and as a potential target to
disrupt progression of cancer. Here we summarize what is known about CDCP1 including its
structural features, expression in normal and cancerous tissues, and the in vitro experiments
and studies in animal models that have provided the key insights into its potential role in …
containing protein 1 (CDCP1) has been associated with several cancers and this cell
surface molecule has been recognized both as a tumor marker and as a potential target to
disrupt progression of cancer. Here we summarize what is known about CDCP1 including its
structural features, expression in normal and cancerous tissues, and the in vitro experiments
and studies in animal models that have provided the key insights into its potential role in …
Abstract
In the last few years dysregulated expression of the cell surface glycoprotein CUB domain‐containing protein 1 (CDCP1) has been associated with several cancers and this cell surface molecule has been recognized both as a tumor marker and as a potential target to disrupt progression of cancer. Here we summarize what is known about CDCP1 including its structural features, expression in normal and cancerous tissues, and the in vitro experiments and studies in animal models that have provided the key insights into its potential role in tumor formation and metastasis in humans. We conclude by highlighting opportunities and challenges in targeting CDCP1 in cancer. © 2009 IUBMB IUBMB Life 61(7): 723–730, 2009
Wiley Online Library